Hypertrophic cardiomyopathy is a disease of cardiac muscle that is often genetically transmitted as. an autosomal dominant trait and is characterized by a wide variety of patterns of left ventricular hypertrophy that may be identified with wide-angle, two-dimensional echocardiography. To determine the degree to which left ventricular morphology is similar in related patients with hypertrophic cardiomyopathy, 40 index cases with this disease and 66 of their affected first-degree relatives were studied by twodimensional echocardiography.
genetically transmitted hypertrophic cardiomyopathy. Furthermore, the morphologic appearance of the left ventricle is particularly variable and markedly dissimilar in most closely related individuals with the genetically transmitted form of hypertrophic cardiomyopathy. This marked morphologic variability in closely related patients suggests that in screening families for hypertrophic cardiomyopathy, both M-mode and two-dimensional echocardiography should be used.
THE MAJORITY of patients with hypertrophic cardiomyopathy appear to have a familial disease,1`5 with the pattern of inheritance usually most consistent with an autosomal dominant trait.3-10 Two-dimensional echocardiography permits identification of a wide variety of patterns of left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. ' l2 However, it is not known whether all the morphologic expressions of hypertrophic cardiomyopathy identifiable with two-dimensional echocardiography may be genetically transmitted, or the degree to which left ventricular morphology is similar in related patients with the familial form of this disease. Hence, we undertook a two-dimensional echocardiographic analysis of first-degree relatives in 40 families with genetically transmitted hypertrophic cardiomyopathy in order to better define the morphologic expression of this disease.
Patients and Methods
Two-dimensional echocardiographic studies performed in the Echocardiography Laboratory of the National Heart, Lung, and Blood Institute from 1979 to 1982 were reviewed. Forty patients with the clini-call3 16 and echocardiographic'7-20 features of hypertrophic cardiomyopathy and technically adequate echocardiograms were identified as index cases of families in which the disease was known to be genetically transmitted to at least one first-degree relative. Sixty-six first-degree relatives of these 40 probands were also identified as having hypertrophic cardiomyopathy, based on the interpretation of technically satisfactory echocardiographic studies. The final study group consisted of 106 patients with hypertrophic cardiomyopathy.
The diagnosis of hypertrophic cardiomyopathy was established with M-mode and two-dimensional echocardiography by the demonstration of a nondilated, hypertrophied left ventricle in the absence of another cardiac or systemic disease which itself could produce left ventricular hypertrophy.2' Six study patients (none of whom were related) had a history of mild systemic hypertension, but were included because they also demonstrated clinical or hemodynamic features consistent with hypertrophic cardiomyopathy and/or because the extent of left ventricular hypertrophy they manifested clearly exceeded that which would have been expected to result from hypertension alone. 22 23 The patients were 4-74 years old (mean 34 years); 61 (58%) were male and 45 (42%) were female. Of the 106 patients, 54 (51%) were asymptomatic, 32 (30%) 1227 VOL 67, No 6, JuNE 1983 had mild functional limitation (New York Heart Association functional class II) and 20 (19%) had moderateto-severe limitation (classes III and IV). Each patient who had experienced substantial symptoms was treated medically with either propranolol or verapamil at some time during their clinical course; three (all probands) had undergone operation (ventricular septal myotomy-myectomy) for obstructive hypertrophic cardiomyopathy.
Magnitude of left ventricular outflow tract obstruction under basal conditions was assessed at cardiac catheterization in 42 patients and estimated from the M-mode echocardiogram based on the magnitude and duration of systolic anterior motion of the mitral valve in 64.24 Left ventricular outflow tract obstruction under basal conditions (gradient 3 30 mm Hg) was present in 15 patients and was absent or < 30 mm Hg in 91.
Characterization of Pedigrees
Of the 40 study families, 23 (58%) consisted of two affected members (including the proband), 11 (27%) had three affected relatives and six (15%) had four to six affected relatives. In 28 pedigrees, the pattern of genetic transmission was most consistent with an autosomal dominant trait (i.e., at least one affected relative was identified in two or more consecutive generations). In the remaining 12 families, a familial occurrence of hypertrophic cardiomyopathy was evident, but the pedigree could not be definitively classified with regard to a particular Mendelian mode of inheritance.
M-mode Echocardiography
M-mode echocardiograms were performed using a 2.25-MHz, 1.25-cm-diameter, unfocused Aerotech transducer and a Hoffrel 201 ultrasound receiver interfaced with a Honeywell 1856 strip-chart recorder. The methods of imaging the ventricular septum and posterior left ventricular free wall have been described. 17 Maximal thickness of the ventricular septum was measured just before atrial systole with the ultrasound beam directed through or slightly below the caudal margins of the mitral leaflets. Thickness of the posterior left ventricular free wall was measured during the same phase of the cardiac cycle, with the ultrasound beam passing through the mitral leaflet tips.
Two-dimensional Echocardiography
A Varian (V-3400 or V-3000) real-time, phasedarray, 800 ultrasonic sector scanner with hand-held 2.25-MHz transducer was used to perform the twodimensional echocardiographic studies. The field of view is 80°in an azimuthal direction and i5 or 21 cm deep. Azimuthal resolution is 2-5 mm within the field of view and range resolution is 1.5-2 mm.25'26 Images were produced at 32 frames/sec and recorded on either 0.5-inch (1.27-cm) (Sanyo) cassette videotape, 1-inch (2.54-cm) (Sony) reel-to-reel videotape or Ampex DR-10 rhodium-plated chromium disc for subsequent review in real-time, slow-motion or stop-action modes. Single still-frame photographs were made from a television monitor using a 35-mm camera.
The two-dimensional echocardiographic examination, performed to identify the distribution of left ventricular hypertrophy, included the imaging of a number of cross-sectional planes through the heart.27 Serial short-axis views of the left ventricle were obtained by initially orienting the sector plane perpendicular to the long axis of the left ventricle from a standard transducer placement on the chest. The short-axis sweep was performed by maintaining the transducer in a fixed location on the chest wall and slowly angling the image plane from aorta (cephalad) to apex (caudad). 28 The apical portions of the anterior regions of the left ventricular wall (i.e., the anterior ventricular septum and anterior free wall) that are not well visualized in the short-axis scan are, however, often identifiable in the long-axis and apical views.
The long-axis view was obtained by orienting the sector plane 900 to the short-axis plane and parallel to the longitudinal axis of the left ventricle, taking care to avoid improper angulation of the scan plane tangentially through the ventricle. The apical four-chamber view was obtained with the transducer placed at the cardiac apex and the tomographic plane directed perpendicular to the ventricular and atrial septa and through the plane of the mitral and tricuspid valve orifices to permit simultaneous display of both atria and ventricles, atrioventricular valves and cardiac septae.29 Finally, the transducer positioned at the left ventricular apex was rotated to the patient's left so that the ultrasound beam was in a plane approximately parallel to the ventricular septum, permitting simultaneous visualization of the aorta (and aortic valve), left ventricular outflow tract and mitral valve leaflets.
Assessment of Left Ventricular Hypertrophy
The location of left ventricular hypertrophy was described in two cross-sectional planes according to previously described criteria", 12 ( fig. 1 ). This analysis used primarily the parastemal short axis and long axis, although the apical views were often used to supplement data obtained from the parasternal views.
In the anteroposterior plane, hypertrophy was designated as involving either the ventricular septum or the left ventricular free wall or both. The ventricular septum was divided into two approximately equal segments (anterior and posterior). The left ventricular free wall was separated into anterior, lateral and posterior segments (figs. IA, B). In the cephalad-caudad plane, the left ventricle was divided into the basal portion, the gray scale and adjusting the controls so as to image the endocardium at the lowest possible gain settings.
Hypertrophy of a segment of left ventricle was considered to be present if the wall was judged to be at least 15 mm thick. We could usually assess this readily by viewing the real-time movie. In some instances, we had to measure wall thickness in the stop-action mode just before atrial systole directly from the television monitor with the aid of calipers, and using a calibration scale produced by the instrument. In such instances, to enhance the accuracy of our observations, the location of endocardial and epicardial surfaces were always verified by viewing the pertinent portions of videotape in slow-motion or real-time modes; furthermore, in some patients, the M-mode echocardiogram was used to verify the thickness of either the anterior ventricular septum or the posterior portion of free wall. To measure ventricular septal thickness by two-dimensional echocardiography, the wall dimension was taken be-tween the most anterior edge of both endocardial lines (i.e., leading-edge method).30' 31 The anterolateral free wall thickness was measured in the short-axis view; the wall dimension was taken from the most anterior or lateral edge of the endocardial line to the apparent epicardial interface (defined as the outer circumferential contour of the left ventricle formed by the transition between specular myocardial echoes and the adjacent zone comprised of brighter echoes). 32 We tried to minimize potential sources of error in the measurement of free wall thickness near the lateral boundary of the sector, where lateral resolution is less optimal, by positioning the anterolateral free wall (as viewed in the short-axis plane) close to the center of the field of view, where lateral resolution is best; this was accomplished by routinely recording at the maximal depth of 21 cm and obtaining short-axis images after sweeping the transducer laterally.
Assessment of the distribution of left ventricular 1229 I VOL 67, No 6, JUNE 1983 hypertrophy is best appreciated by analysis of realtime (motion) recordings. The freeze-frame photographs used in this report for purposes of illustration do not permit the visual integration that is possible with motion and the quality of such static images is also unavoidably degraded optically compared with the dynamic real-time display.
Classification of Morphologic Types Four basic patterns of distribution of left ventricular hypertrophy were identified by two-dimensional echocardiography in the study patients. This classification has been reported in detail"' and is also briefly described here.
Type I hypertrophy was confined to the anterior segment of the ventricular septum, involving usually the basal region alone but often both the basal and apical regions; the left ventricular free wall and posterior portion of ventricular septum appeared essentially normal. Type II hypertrophy involved both anterior and posterior segments of the ventricular septum; the left ventricular free wall appeared essentially normal. Type III hypertrophy involved substantial portions of both the ventricular septum and left ventricular free wall; the predominant region of hypertrophy was usually the anterior or posterior segment of ventricular septum and often the only portion of the left ventricle free of hypertrophy was the posterior free wall. Type IV hypertrophy involved regions of the left ventricular wall other than the anterior, basal ventricular septum, i.e., posterior segment of the septum, anterolateral free wall or septum in its apical half. In each patient with type IV hypertrophy, M-mode echocardiography failed to show evidence of hypertrophy because left ventricular wall thickening was situated in regions of the left ventricle that were inaccessible to the path of the conventional M-mode echo beam; however, two-dimensional echocardiography did permit identification of these regions of hypertrophy. 12
Segmental Analysis of the Distribution of Left Ventricular Hypertrophy
In addition to the morphologic classification just described, the presence or absence of hypertrophy was also assessed in individual segments of left ventricular wall. Specifically, for the purposes of this data analysis, we considered the left ventricular wall to be subdivided into 10 segments; anterior and posterior ventricular septum in both the basal and apical portions of the left ventricle as well as anterior, lateral and posterior free wall in both the basal and apical portions of the left ventricle ( fig. 1 ). The segmental pattern of left ventricular hypertrophy was then compared in all possible combinations of pairs of first-degree relatives in each family (a total of 105 pairs for the 106 study patients). For example, if a given family consisted of only two relatives with hypertrophic cardiomyopathy, these subjects were simply compared. However, if a family consisted of three affected relatives (A, B and C), morphologic comparisons were made between relatives A and B, relatives B and C and relatives A and C.
Two first-degree relatives were considered morphologically identical when hypertrophy involved the same segments of left ventricular wall in each member of the pair. (2) Two relatives were morphologically similar when only one or two segments differed with regard to the presence or absence of hypertrophy, i.e., hypertrophy involved at least eight of the same segments in both members of the pair. (3) Two relatives were morphologically dissimilar when three or more segments differed with regard to the presence or absence of hypertrophy.
The presence or absence of hypertrophy in individual segments of left ventricular wall was assessed in each patient independently by two observers; concordant observations were attained by the two observers in 95% of the instances. However, where discrepancies arose, those studies were reviewed and agreement was achieved.
Results

M-mode Echocardiography
In the 106 study patients, ventricular septal thicknesses ranged from 7 to 40 mm (mean 19 mm); posterior left ventricular free wall thickness ranged from 6 to 16 mm (mean 13 mm). In 83 patients (78%) the septalfree wall thickness ratio was ¢ 1. 3, meeting our criteria for asymmetric septal hypertrophy.'7 One patient had concentric (symmetric) left ventricular wall thickening (septal-free wall thickness ratio < 1.3); 22 patients (21%) had normal ventricular wall thicknesses and septal-free wall ratios.'2 Two-dimensional Echocardiography: Comparison of Distribution of Hypertrophy in First-degree Relatives
Morphologic Type
Each of the four morphologic types characteristic of hypertrophic cardiomyopathy"I was identified by twodimensional echocardiography in at least one study patient. Most often (51 of 106 patients, 48%), relatives showed extensive distribution of hypertrophy involving substantial portions of the septum and free wall (type III). Hypertrophy located in regions of left ventricular wall other than basal anterior ventricular septum (type IV) was identified in 21 patients (20%); this included nine patients in whom ventricular septal hypertrophy was confined to the apical half of the left ventricle (apical hypertrophic cardiomyopathy).33 34 Nineteen patients (18%) showed substantial hypertrophy of only ventricular septum (type II) and 15 (14%) had hypertrophy confined to the anterior ventricular septum (type I).
Only 41 of the 105 pairs of first-degree relatives (39%) demonstrated phenotypically similar hearts, i.e., with the same morphologic type. Of these, 26 showed type III, nine were type IV, four type I and two type II hypertrophy.
Segmental Wall Analysis
When the morphologic appearance of the left ventri-The data were then described in the following way: (1) 1230 CIRCULATION cle was described using the more precise segmental 2-4) . The data were also analyzed with respect to individual families. Only dissimilar morphologic pairs were present in 21 of the 40 pedigrees (53%), only similar or identical pairs were identified in six (15%) and both dissimilar and similar (or identical) were present in 13 (32%).
Relation Between Inherited Patterns of Left Ventricular Hypertrophy and Hemodynamic State
To determine whether differences in left ventricular morphology between first-degree relatives could be explained solely on the basis of hemodynamic state, the magnitude of left ventricular outflow tract obstruction under basal conditions was also analyzed in each relative. Of the 73 pairs of relatives with dissimilar distribution of left ventricular hypertrophy, only 11 (15%) showed substantially different hemodynamic states, i.e., one member of the pair had obstruction to left ventricular outflow while the other had no or minimal subaortic obstruction. Discussion The present two-dimensional study demonstrates that virtually echocardiographic all patterns of left \ALFW X | | |~~B./ POSTERIOR FW FIGURE 3 . Stop frames of two-dimensional echocardiograms (during diastole in the short-axis view) from two first-degree relatives who showed dissimilar distribution ofhypertrophy and morphologic expression ofhypertrophic cardiomyopathy. (A) Hypertrophy is present in only the anterior andposterior segments ofventricular septum (VS); the left ventricular free wall is not thickened. (B) Brother of the patient in A. Hypertrophy is primarity confined to the anterolateralfree wall (ALFW). The regions of left ventricular wall through which the M-mode beam passes, i.e., anterior ventricular septum and posteriorfree wall (FW), are not thickened. AML = anterior mitral leaflet; PML = posterior mitral leaflet. ventricular hypertrophy in patients with hypertrophic cardiomyopathy may constitute a manifestation of the genetically transmitted form of the disease. Using our morphologic typing classification to describe left ventricular anatomy, we found that hypertrophy involving substantial portions of both ventricular septum and left ventricular free wall (type III) was the most common morphologic expression encountered in the present study group, although each of the other three morphologic types were also identified in at least 10% of the relatives with hypertrophic cardiomyopathy that we studied. Furthermore, using a more precise analysis of segments of left ventricular wall for the presence of hypertrophy, we could define 49 diverse patterns of left ventricular hypertrophy. When left ventricular anatomy was compared in closely related patients with hypertrophic cardiomyopathy (using either of the two morphologic analyses used in this study), the distribution of left ventricular hypertrophy was distinctly dissimilar in about two-thirds of the relatives studied. In only about one-third of our patients did the pattern of hypertrophy appear similar, including only eight pairs of relatives with an identical morphologic expression of hypertrophic cardiomyopathy. The precise explanation for the variable morphologic expression of hypertrophic cardiomyopathy in relatives is unclear and its definition is beyond the scope of the present paper. However, it seems most likely that these differences in left ventricular anatomy are of primary genetic origin and not secondary to clinical findings, such as the magnitude of left ventricular outflow gradient. Certainly, the variable morphologic expressivity we identified in genetically transmitted hypertrophic cardiomyopathy is also characteristic of noncardiac diseases that are inherited in an autosomal dominant pattern. 35 Although the distinctly different phenotypes we observed in first-degree relatives with hypertrophic cardiomyopathy could have emanated from different genes at a variety of loci, it is probably more likely that these phenotypes represent variable expressions of a single gene.
Our findings also have relevance to the problem of diagnostic screening of asymptomatic relatives for hypertrophic cardiomyopathy. Twenty percent of the relatives in this study with hypertrophic cardiomyopathy showed hypertrophy located in regions of the left ventricular wall other than the anterior, basal ventricular septum (i.e., type IV). Hence, in this sizable subgroup of patients, the diagnosis of hypertrophic cardiomyopathy could not be made with M-mode echocardiography alone, since the hypertrophy was situated in regions of the left ventricle that were inaccessible to the M-mode echo beam.'2 In such patients, who would have gone unrecognized if evaluated by M-mode echocardiography alone, two-dimensional echocardiography was essential for establishing the diagnosis of hypertrophic cardiomyopathy. The fact that about 30% of our patients with "typical" patterns of left ventricular hypertrophy that could be identified by Mmode echocardiography had relatives with "unusual" locations of hypertrophy requiring two-dimensional echocardiography emphasizes that both ultrasound methods should be used for reliable detection of hypertrophic cardiomyopathy in families suspected of having relatives with this disease.
